Preliminary SABEDTIO data from IDWeek 2026 show early dual IV therapy cut prolonged S aureus bacteremia to 6% from 16%, with safe oral transition at 72 hours.
Arif R. Sarwari, MD, MSc, MBA
Advertisement
Sarwari is an associate dean for Clinical Affairs, School of Medicine professor, Infectious Diseases, West Virginia University,
Articles by Arif R. Sarwari, MD, MSc, MBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Ebola Update: DRC Outbreak Reaches 9735 Cases, Second Largest on Record
2
Pritelivir Cuts Hospital Days in Refractory HSV in Phase 3 PRIOH-1
3
Cefiderocol-Xeruborbactam Active Against Carbapenem-Resistant Bacteria
4
Pfizer 25-Valent Pneumococcal Vaccine Boosts Serotype 3 Response in Infants
5